162 related articles for article (PubMed ID: 7803243)
1. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease.
Le Van Kim C; Mouro I; Brossard Y; Chavinié J; Cartron JP; Colin Y
Br J Haematol; 1994 Sep; 88(1):193-5. PubMed ID: 7803243
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
[TBL] [Abstract][Full Text] [Related]
3. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB
Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of prenatal determination of RhD type status by polymerase chain reaction with amniotic cells.
Lighten AD; Overton TG; Sepulveda W; Warwick RM; Fisk NM; Bennett PR
Am J Obstet Gynecol; 1995 Oct; 173(4):1182-5. PubMed ID: 7485316
[TBL] [Abstract][Full Text] [Related]
5. Prenatal determination of fetal rhesus D status by DNA amplification of peripheral blood of rhesus-negative mothers.
Lo YM; Bowell PJ; Selinger M; Mackenzie IZ; Chamberlain P; Gillmer MD; Elliott P; Pratt G; Littlewood TJ; Fleming KA
Ann N Y Acad Sci; 1994 Sep; 731():229-36. PubMed ID: 7944125
[TBL] [Abstract][Full Text] [Related]
6. DNA-based prenatal determination of the RhEe genotype.
Spence WC; Potter P; Maddalena A; Demers DB; Bick DP
Obstet Gynecol; 1995 Oct; 86(4 Pt 2):670-2. PubMed ID: 7675408
[TBL] [Abstract][Full Text] [Related]
7. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
[TBL] [Abstract][Full Text] [Related]
8. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive fetal RhCE genotyping from maternal blood.
Geifman-Holtzman O; Grotegut CA; Gaughan JP; Holtzman EJ; Floro C; Hernandez E
BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
[TBL] [Abstract][Full Text] [Related]
10. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers.
Lo YM; Bowell PJ; Selinger M; Mackenzie IZ; Chamberlain P; Gillmer MD; Littlewood TJ; Fleming KA; Wainscoat JS
Lancet; 1993 May; 341(8853):1147-8. PubMed ID: 8097823
[No Abstract] [Full Text] [Related]
11. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
12. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
13. Prenatal determination of fetal RhD type by DNA amplification.
Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP
N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal typing of Rh- and Kell- blood group system antigens].
Faas BH; Maaskant-van Wijk PA; Beuling EA; Overbeeke MA; van der Schoot CE; Christiaens GC
Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1804-7. PubMed ID: 10526582
[TBL] [Abstract][Full Text] [Related]
15. RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype.
Denomme GA; Akoury H; Sermer M; Kelton JG
Prenat Diagn; 1999 May; 19(5):424-7. PubMed ID: 10360510
[TBL] [Abstract][Full Text] [Related]
16. Rh haemolytic disease of the newborn and Rh genotyping by RFLP--and allele-specific--PCR.
Le Van Kim C; Colin Y; Brossard Y; Cartron JP
Transfus Clin Biol; 1995; 2(4):317-24. PubMed ID: 8542030
[No Abstract] [Full Text] [Related]
17. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
[TBL] [Abstract][Full Text] [Related]
18. [Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects].
Orzińska A; Guz K; Brojer E
Ginekol Pol; 2009 Oct; 80(10):768-71. PubMed ID: 19943542
[TBL] [Abstract][Full Text] [Related]
19. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
20. Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn.
Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Racca A
Clin Exp Med; 2002 Jul; 2(2):77-81. PubMed ID: 12141530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
